TCL Archive Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML December 28, 2007
TCL Archive DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio January 1, 1988